ImmunoForge Co., Ltd., a clinical-stage biopharmaceutical company specializing in treatments for rare and muscular diseases, ...
Series A financing will be used to advance Aerska's brain shuttle technology to improve the delivery of RNA interference therapeutics for neurological diseases Financing was co-led by EQT Life ...
The blood-brain border has long stymied drug development for neurodegenerative diseases. In recent years, Denali, Roche, and others have designed molecular brain shuttles that ferry investigational ...
HONG KONG, March 13 (Reuters) - China's drug regulator said on Friday that it has given the nod for a brain-computer interface (BCI) system that helps restore hand-movement ability to be sold, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results